The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Knowledge Gaps and Future Direction in Assessment and Treatment

CARG-HNC Study Group

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Older adults with head and neck squamous cell carcinoma (HNSCC) pose unique treatment and supportive care challenges to oncologists and other cancer care providers. The majority of patients with HNSCC present with locoregionally advanced disease, for which combined-modality treatment integrating chemotherapy and radiation therapy is often necessary to maximize tumor control. However, applying these approaches to an older population with concomitant comorbidities and a higher risk of functional impairments remains challenging and is exacerbated by the paucity of studies involving older adults. The purpose of this article is to identify knowledge gaps in the evaluation and management of older adults with HNSCC—particularly those undergoing concurrent chemoradiation therapy—and their caregivers through a review of the literature conducted by clinicians, researchers, and patient advocates. The findings highlight the importance of a geriatric assessment and the therapeutic paradigms and challenges relevant to this population. Furthermore, we identify the need for additional research and interventions related to key supportive care issues that arise during and after treatment in older adults with locoregionally advanced HNSCC. On the basis of our findings, we prioritize these issues to guide future patient-oriented research endeavors to address these knowledge gaps and thus better serve this growing patient population.

Original languageEnglish (US)
Pages (from-to)868-883
Number of pages16
JournalInternational Journal of Radiation Oncology Biology Physics
Volume98
Issue number4
DOIs
StatePublished - Jul 15 2017

Fingerprint

cancer
geriatrics
Population
Geriatric Assessment
impairment
Therapeutics
chemotherapy
Research
Caregivers
Comorbidity
radiation therapy
therapy
Neoplasms
Radiotherapy
tumors
Research Personnel
Drug Therapy
Direction compound
Carcinoma, squamous cell of head and neck
evaluation

All Science Journal Classification (ASJC) codes

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

@article{fda6e59e3e5c4792b6f892f69979ecde,
title = "The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment",
abstract = "Older adults with head and neck squamous cell carcinoma (HNSCC) pose unique treatment and supportive care challenges to oncologists and other cancer care providers. The majority of patients with HNSCC present with locoregionally advanced disease, for which combined-modality treatment integrating chemotherapy and radiation therapy is often necessary to maximize tumor control. However, applying these approaches to an older population with concomitant comorbidities and a higher risk of functional impairments remains challenging and is exacerbated by the paucity of studies involving older adults. The purpose of this article is to identify knowledge gaps in the evaluation and management of older adults with HNSCC—particularly those undergoing concurrent chemoradiation therapy—and their caregivers through a review of the literature conducted by clinicians, researchers, and patient advocates. The findings highlight the importance of a geriatric assessment and the therapeutic paradigms and challenges relevant to this population. Furthermore, we identify the need for additional research and interventions related to key supportive care issues that arise during and after treatment in older adults with locoregionally advanced HNSCC. On the basis of our findings, we prioritize these issues to guide future patient-oriented research endeavors to address these knowledge gaps and thus better serve this growing patient population.",
author = "{CARG-HNC Study Group} and Ronald Maggiore and Zumsteg, {Zachary S.} and Karlynn BrintzenhofeSzoc and Trevino, {Kelly M.} and Ajeet Gajra and Beatriz Korc-Grodzicki and Epstein, {Joel B.} and Bond, {Stewart M.} and Ira Parker and Kish, {Julie A.} and Murphy, {Barbara A.} and Noam Vanderwalde",
year = "2017",
month = "7",
day = "15",
doi = "10.1016/j.ijrobp.2017.02.022",
language = "English (US)",
volume = "98",
pages = "868--883",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

T2 - Knowledge Gaps and Future Direction in Assessment and Treatment

AU - CARG-HNC Study Group

AU - Maggiore, Ronald

AU - Zumsteg, Zachary S.

AU - BrintzenhofeSzoc, Karlynn

AU - Trevino, Kelly M.

AU - Gajra, Ajeet

AU - Korc-Grodzicki, Beatriz

AU - Epstein, Joel B.

AU - Bond, Stewart M.

AU - Parker, Ira

AU - Kish, Julie A.

AU - Murphy, Barbara A.

AU - Vanderwalde, Noam

PY - 2017/7/15

Y1 - 2017/7/15

N2 - Older adults with head and neck squamous cell carcinoma (HNSCC) pose unique treatment and supportive care challenges to oncologists and other cancer care providers. The majority of patients with HNSCC present with locoregionally advanced disease, for which combined-modality treatment integrating chemotherapy and radiation therapy is often necessary to maximize tumor control. However, applying these approaches to an older population with concomitant comorbidities and a higher risk of functional impairments remains challenging and is exacerbated by the paucity of studies involving older adults. The purpose of this article is to identify knowledge gaps in the evaluation and management of older adults with HNSCC—particularly those undergoing concurrent chemoradiation therapy—and their caregivers through a review of the literature conducted by clinicians, researchers, and patient advocates. The findings highlight the importance of a geriatric assessment and the therapeutic paradigms and challenges relevant to this population. Furthermore, we identify the need for additional research and interventions related to key supportive care issues that arise during and after treatment in older adults with locoregionally advanced HNSCC. On the basis of our findings, we prioritize these issues to guide future patient-oriented research endeavors to address these knowledge gaps and thus better serve this growing patient population.

AB - Older adults with head and neck squamous cell carcinoma (HNSCC) pose unique treatment and supportive care challenges to oncologists and other cancer care providers. The majority of patients with HNSCC present with locoregionally advanced disease, for which combined-modality treatment integrating chemotherapy and radiation therapy is often necessary to maximize tumor control. However, applying these approaches to an older population with concomitant comorbidities and a higher risk of functional impairments remains challenging and is exacerbated by the paucity of studies involving older adults. The purpose of this article is to identify knowledge gaps in the evaluation and management of older adults with HNSCC—particularly those undergoing concurrent chemoradiation therapy—and their caregivers through a review of the literature conducted by clinicians, researchers, and patient advocates. The findings highlight the importance of a geriatric assessment and the therapeutic paradigms and challenges relevant to this population. Furthermore, we identify the need for additional research and interventions related to key supportive care issues that arise during and after treatment in older adults with locoregionally advanced HNSCC. On the basis of our findings, we prioritize these issues to guide future patient-oriented research endeavors to address these knowledge gaps and thus better serve this growing patient population.

UR - http://www.scopus.com/inward/record.url?scp=85020477708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020477708&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2017.02.022

DO - 10.1016/j.ijrobp.2017.02.022

M3 - Article

VL - 98

SP - 868

EP - 883

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -